Randamized clinical study with tioropium and formoterol/budezonide in COPD with asthma

Randamized clinical study with tioropium and formoterol/budezonide in COPD with asthma - Randamized clinical study with tioropium and formoterol/budezonide in COPD with asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003618

Enrollment

Registered

2010-07-01

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD with asthma

Interventions

Tiotropium + Formoterol/Budezonide Tiotropium + Budezonide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD with asthma who is in out-patient

Exclusion criteria

Exclusion criteria: # the patient who is not diagzoned as COPD # the patient who needs other medicines # the patient who has glaucoma or BPH # the patient who has allergy in tiotropium, formoterol, budezonide

Design outcomes

Primary

Measure	Time frame
Lung function	—

Countries

Japan

Contacts

Public ContactToshitaka Maeno

Saitama Medical University Pulmonary Division

049-276-1319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026